COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,673 Articles (22,913 medRxiv, 8,760 bioRxiv)

Most recent first Previous |  Page 1122: Articles 11211-11220  | Next

Omicron strain spreads with the doubling time of 3.2-3.6 days in South Africa province of Gauteng that achieved herd immunity to Delta variant
Grabowski, F., Kochanczyk, M., Lipniacki, T.
10.1101/2021.12.08.21267494 — Posted: 2021-12-09
Population Optimally Immunized after Accounting for Type-Specific COVID-19 Vaccine Waning Intervals: State-Level Prevalence and Trends
Pathak, E. B., Salemi, J. L.
10.1101/2021.12.09.21267295 — Posted: 2021-12-09
The unequal impact of the COVID-19 pandemic on life expectancy across Chile
Mena, G. E., Aburto, J. M.
10.1101/2021.12.08.21267475 — Posted: 2021-12-09
Surveillance of COVID-19 vaccine effectiveness - a real-time case-control study in southern Sweden
Bjork, J., Bonander, C., Moghaddassi, M., Rasmussen, M., Malmqvist, U., Kahn, F., Inghammar, M.
10.1101/2021.12.09.21267515 — Posted: 2021-12-09
Superspreading of SARS-CoV-2 infections: A Systematic Review and Meta-analysis
Du, Z., Wang, C., Liu, C., Bai, Y., Sen, P., Adam, D., Wang, L., Wu, P., Lau, E., Cowling, B. J.
10.1101/2021.12.09.21267507 — Posted: 2021-12-09
Changes in the trajectory of Long Covid symptoms following COVID-19 vaccination: community-based cohort study
Ayoubkhani, D., Bermingham, C., Pouwels, K. B., Glickman, M., Nafilyan, V., Zaccardi, F., Khunti, K., Alwan, N. A., Walker, A. S.
10.1101/2021.12.09.21267516 — Posted: 2021-12-09
Access to healthcare as an important moderating variable for understanding geography of immunity levels for COVID-19 - preliminary insights from Poland
Jarynowski, A., Belik, V.
10.1101/2021.12.08.21267167 — Posted: 2021-12-09
The Landscape-Based Protein Stability Analysis and Network Modeling of Multiple Conformational States of the SARS-CoV-2 Spike D614 Mutant: Conformational Plasticity and Frustration-Driven Allostery as Energetic Drivers of Highly Transmissible Spike Variant
Verkhivker, G., Agajanian, S., Kassab, R., Krishnan, K.
10.1101/2021.12.09.471953 — Posted: 2021-12-09
SARS-CoV-2 Omicron Spike Glycoprotein Receptor Binding Domain Exhibits Super-Binder Ability with ACE2 but not Convalescent Monoclonal Antibody
Omotuyi, O. I., Olujide, O., Nash, O., Afolabi, E. O., Oyinloye, B., Fatumo, S., Femi-Oyewo, M., Bogoro, S.
10.1101/2021.12.09.471885 — Posted: 2021-12-09
Modeling COVID-19 Aerosol Transmission in Primary Schools
Swanson, T., Guikema, S. D., Bagian, J., Payne, C.
10.1101/2021.12.08.21267499 — Posted: 2021-12-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).